Roth Capital lowered the firm's price target on Celsius to $57 from $65 and keeps a Buy rating on the shares. The firm reduced estimates ahead of the company's Q2 report to reflect a moderation in the overall growth for the North America energy drink category relative to 2025. Market share for the Celsius brand continues to lag Roth's expectations, the analyst tells investors in a research note. The firm believes rationalizations within the portfolio are contributing to Celsius' near-term revenue headwinds. However, Roth continues to expect Alani to outperform the energy category and the Celsius brand to show better year-over-year performance in the back half of 2026. Despite trimming estimates, the firm views the stock as undervalued relative to the company's growth potential.
